The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy

AIDS

Volumn 12, Issue 11, 1998, Pages

  Hoetelmans, Richard M W ^a   Reijers, Monique H E ^b,c   Weverling, Gerrit J ^b   Ten Kate, Reinier W ^d   Wit, Ferdinand W N M ^b   Mulder, Jan W ^a   Weigel, Hugo M ^c   Jos Frissen, P H ^c   Roos, Marijke ^e   Jurriaans, Suzanne ^b   Schuitemaker, Hanneke ^e   De Wolf, Frank ^b   Beijnen, Jos H ^a   Lange, Joep M A ^b  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^d Infection and Immunology   (Netherlands)

^e CENTRAL LABORATORY   (Netherlands)

Author keywords

HIV 1 clearance rate; Nelfinavir; Pharmacokinetics; Saquinavir; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; LAMIVUDINE; NELFINAVIR; SAQUINAVIR; STAVUDINE; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 15144339409     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199811000-00002     Document Type: Article

References (8)

1. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
2. Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
3. Lange JMA: Current problems and the future of antiretroviral drug trials. Science 1997, 276:548-550.
4. Nowak MA, Bonhoeffer S, Loveday C, et al.: HIV results in the frame. Results confirmed. Nature 1995, 375:193.
5. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996, 271:1582-1586.
6. Merry C, Barry MG, Mulcahy F, Halifax KL, Back DJ: Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV-infected patients. AIDS 1997, 11:F117-F120.
7. Hoetelmans RMW, van Essenberg M, Meenhorst PL, Mulder JW, Beijnen JH: Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection. J Chrom B 1997, 698:235-241.
8. Havlir DV, Hirsch M, Collier A, et al.: Randomized trial of indinavir (IDV) vs. zidovudine (ZDV)/lamivudine (3TC) vs. IDV/ZDV/3TC maintenance therapy after induction IDV/ZDV/3TC therapy. 5th Conference on Retroviruses and Opportunistic Infections. Chicago, February 1998 [abstract LB16].